Alasdair Maclean
- Epidemiology top 2%
- Genetics top 2%
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Co-authors
- Stuart M. BrownJ. HarlandNicholas FraserJ. H. Subak‐SharpeJ G SpivackS. M. BrownI. SteinerE. A. McKie
- Topics
- Herpesvirus Infections and Treatments (32 papers)Virus-based gene therapy research (20 papers)Cytomegalovirus and herpesvirus research (13 papers)
- Cited by
- VirologyEpidemiologyGenetics
- Partner nations
- United KingdomSlovakiaUnited States
In The Last Decade
Alasdair Maclean
50 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 97
- Epidemiology 1.4k
- Genetics 817
- Molecular Biology 420
- Immunology 346
- Oncology 287
Countries citing papers authored by Alasdair Maclean
This map shows the geographic impact of Alasdair Maclean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alasdair Maclean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alasdair Maclean more than expected).
Fields of papers citing papers by Alasdair Maclean
This network shows the impact of papers produced by Alasdair Maclean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alasdair Maclean. The network helps show where Alasdair Maclean may publish in the future.
Co-authorship network of co-authors of Alasdair Maclean
This figure shows the co-authorship network connecting the top 25 collaborators of Alasdair Maclean. A scholar is included among the top collaborators of Alasdair Maclean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alasdair Maclean. Alasdair Maclean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | Replication characteristics of herpes simplex virus type-1 (HSV-1) recombinants in 3 types of tissue cultures | 2 |
| 6 | 8 | |
| 7 | 8 | |
| 8 | 9 | |
| 9 | 39 | |
| 10 | Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma. | 96 |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 73 | |
| 14 | 52 | |
| 15 | 19 | |
| 16 | 22 | |
| 17 | 29 | |
| 18 | 27 | |
| 19 | 219 | |
| 20 | 23 |
About Alasdair Maclean
Alasdair Maclean is a scholar working on Virology, Epidemiology and Genetics, having authored 52 papers that have together received 1.8k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (32 papers), Virus-based gene therapy research (20 papers) and Cytomegalovirus and herpesvirus research (13 papers). The work is most often cited by research in Virology (246 citations), Epidemiology (1.4k citations) and Genetics (817 citations). Alasdair Maclean has collaborated with scholars based in United Kingdom, Slovakia and United States. Frequent co-authors include Stuart M. Brown, J. Harland, Nicholas Fraser, J. H. Subak‐Sharpe, J G Spivack, S. M. Brown, I. Steiner, E. A. McKie, Ronald P. Lirette and Rory Gunson. Their work appears in journals such as The EMBO Journal, Journal of Virology and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.